Julie Skinner (Anderton) serves as Vice President at Pfizer since September 2022, following a tenure at Merck from June 2007 to September 2022 as Senior Principal Scientist. Julie Skinner's extensive experience in the vaccine sector includes leadership roles in bacterial vaccine programs, overseeing pre-clinical studies, and contributing to regulatory filings and patent applications. With a PhD in Molecular Microbiology from Stony Brook University and a BS in Biology from Coastal Carolina University, Julie Skinner possesses a strong technical skill set in microbiology, molecular biology, and immunology, complemented by roles at the CDC and other organizations. Julie Skinner's collaborative approach has facilitated successful partnerships in advancing vaccine development efforts.
This person is not in the org chart
This person is not in any teams
This person is not in any offices